Dr. Kellie R. Satterfield, MD

Dr. Satterfield practices at UCSD Ambulatory Surgery Center, LLC in La Jolla, California.

Dr. Satterfield's NPI, 1629509336, was assigned on March 23, 2017. Dr. Satterfield graduated from UC San Diego School of Medicine in 2017. Dr. Satterfield's California license number on file is A187209.

Dr. Satterfield's primary practice is UCSD Ambulatory Surgery Center, LLC, at 4120 La Jolla Village Dr, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 657-0055.

Dr. Satterfield's primary practice is UCSD Ambulatory Surgery Center, LLC in La Jolla, California. Dmand AI also links Dr. Satterfield to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satterfield practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Satterfield's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Satterfield is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Satterfield's licenses on file in 2 states: California and Washington.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Satterfield treats.

CMS data shows 395 Medicare services from Dr. Satterfield across 6 procedure codes in 2024, for 180 Medicare patients. Medicare paid $23,718 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Dr. Satterfield in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Satterfield's median patient age at 67, with 61% women.

In 2024, Dr. Satterfield wrote 160 Medicare Part D claims for 101 patients. 56% of them were for generic drugs. CMS names the drug for 135 of them, across 6 drugs with 11 or more claims each, at $33,236 in total drug cost. In 2023, CMS named 49 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Satterfield for performance year 2024, reported as part of a group. Dr. Satterfield accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Satterfield, published from 2018 to 2023. The most frequent topics are Eyelids. Dr. Satterfield has published most often in Ophthalmic Plast Reconstr Surg. Dr. Satterfield's most frequent co-authors are Don O. Kikkawa, MD, Audrey C. Ko, MD and Bobby S. Korn, MD.

CMS Open Payments shows 111 general payments to Dr. Satterfield from 14 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Tarsus Pharmaceuticals, Inc. paid the most, $74,028.

Dmand AI lists 3 awards for Dr. Satterfield, most recently Best Eye Doctor in 2024.

Dr. Satterfield graduated from UC San Diego School of Medicine in 2017.

Dr. Satterfield is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.